期刊文献+

虚寒状态大鼠cAMP变化机制的实验研究 被引量:15

Experimental Study on the Potential Changing Mechanism of cAMP in Asthenia Cold Syndrome Rats
下载PDF
导出
摘要 目的观察虚寒状态下大鼠血浆第二信使环磷酸腺苷(cAMP)含量变化,探讨其可能机制。方法将大鼠随机分为正常组和虚寒模型组,虚寒组每日肌肉注射氢化可的松注射液,正常组每日肌肉注射等量生理盐水,持续14d;处死动物,检测甲状腺激素三碘甲腺原氨酸(T3)、甲状腺素(T4)、反三碘甲腺原氨酸(rT3)、肾上腺皮质激素皮质醇(COR)、环磷酸腺苷(cAMP)、环磷酸鸟苷(cGMP)、腺苷酸环化酶(AC)、三磷酸腺苷(ATP)。结果虚寒状态内分泌激素T3、T4、rT3、COR水平降低,cAMP水平、AC活性降低,ATP含量升高。结论虚寒状态下甲状腺、肾上腺皮质功能降低,内分泌激素作用于AC,对AC活化降低,第二信使cAMP生成减少,其介导的生物学效应相应降低,故虚寒机体表现出抑制的状态。 Objective To investigate the change of endocrine, cAMP and potential mechanism in asthenia cold syndrome rats. Method The rats were randomly divided into normal group and asthenia cold model group. The model group were treated with intramuscular injection of hydrocortisone for 14 days, and the normal group with NS. The content of cyclic adenosine monophosphate (cAMP) and adenylate cyclase (AC), triiodothyronine (T3), thyroxine (T4), dopamine (rT3), cortisol (COR), cyclic guanosine monophosphate (cGMP) was detected by radioimmunoassay (RIA). The content of adenosine triphosphate (ATP) was detected by chemiluminescence. Result The content of T3, T4, rT3, COR, cAMP were decreased, the activity of AC was decreased, the conent of ATP was increased. Conclution The function of the endocrine system was suppressed in asthenia cold rats, which can down-regulate cAMP and lead to asthenia cold syndrome.
出处 《中国中医药信息杂志》 CAS CSCD 2010年第2期33-34,共2页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家重点基础研究发展计划(2007CB512605)
关键词 虚寒状态 环磷酸腺苷 腺苷酸环化酶 三磷酸腺苷 内分泌激素 大鼠 asthenia cold syndrome cAMP AC ATP endocrine hormone rat
  • 相关文献

参考文献7

二级参考文献16

  • 1袁晓军,顾龙君,赵惠君,唐跃年,赵金彩,陈静,潘慈.高效液相色谱法测定急性白血病儿童细胞色素P450 3A4活性的探讨[J].中国当代儿科杂志,2005,7(2):137-140. 被引量:3
  • 2张均田.现代药理实验方法[M].北京:北京医科大学中国协和医科大学联合出版社,1998.1151.
  • 3Zhang Y, Benet LZ. The gut as abarrier to drug absorption :combined role of cytochrome P4503A and P - glycoprotein[J]. Clin Pharmacokinet,2001,40(3) :159.
  • 4Cummins CL,Jacobsen W, Benet LZ. Unmasking the dynamic interplay between intestinal P- glycoprotein and CYP3A4[J]. J Pharmacol Exp Ther ,2002,7 : 1036.
  • 5William T. Beck. Methods to Detect P - Glycoprotein - associated Multidrug Resistance in PatientsTumors: Consensus Recommendations [ J ]. Cancer Research, 1996,56 ( 1 ) :3010 - 3020.
  • 6Alfred H, Sehinkel. Characterization of the Human MDR3 P - Glyco- protein and Its Recognition by P - Glycoprotein - specific Monoclonal Antibodies[J]. Cancer Researoh,1991,51 (15) :2628 -2635.
  • 7Severine Lesoux. Glucose Depletion Enhances P - Glyeoprotein Expression in Hepatoma Cell Endoplasmie Betieulum Stress Response[J].Cancer Research ,2003,63( 1 ) :7284 -7290.
  • 8Kharasch ED,Walker A, Hoffer C, et al. Evaluation of first - pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination [ J ]. Clin Pharmacol,2005, 45(1) :79-88.
  • 9Sambuy Y, Ferruzza S, Ranaldi G, et al. Intestinal cell culture models: applications In oxicology and pharmacology [ J ]. Cell Biol Toxicol,2001,17:301 -317.
  • 10朱惠民,陈崇义,高优真,姚玉霞,赵文元,尹桂山,王学孟,王桂香,王凤荣,王俊灵,于志恒.高碘地方甲状腺肿发病机理的研究(1)[J]河北医学院学报,1986(04).

共引文献52

同被引文献183

引证文献15

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部